Skip to main content
. 2021 Aug 4;10(8):1245. doi: 10.3390/antiox10081245

Figure 2.

Figure 2

Synthesis and characterization of TAT-HA-Prdx6WT, TAT-HA-Prdx6K122/142R, and TAT-HA-Prdx6Inactive-mutant protein-loaded nanoparticles. (A) Schematic representation of TAT-HA-Prdx6 protein analog-loaded nanoparticles made by the emulsion solvent evaporation technique [61,74]. (B) Zeta potential of TAT-HA-Prdx6WT-NPs, TAT-HA-Prdx6K122/142R-NPs, and TAT-HA-Prdx6Inactive-mutant-NPs before and after lyophilization. Surface charge (zeta potential) of encapsulants prepared by mixing 1:50 ratio of TAT-HA-Prdx6 protein analog-NPs with DH2O. Standard error (mean ± SD) for n = 3. (C) Representation of atomic force microscopy (AFM) images showing homogenous particle distribution. AFM image (inset, image after dilution) and corresponding size (diameter—nm) distributions of TAT-HA-Prdx6 protein analog NPs.